PT - JOURNAL ARTICLE AU - Lewis, Madison AU - Santini, Tales AU - Theis, Nicholas AU - Muldoon, Brendan AU - Keshavan, Matcheri S. AU - Prasad, Konasale M. TI - Aberrant modularity and lower resiliency of structural covariance network in first-episode antipsychotic-naive psychoses AID - 10.1101/2021.10.08.21264777 DP - 2021 Jan 01 TA - medRxiv PG - 2021.10.08.21264777 4099 - http://medrxiv.org/content/early/2021/10/11/2021.10.08.21264777.short 4100 - http://medrxiv.org/content/early/2021/10/11/2021.10.08.21264777.full AB - Objective Structural brain alterations are consistently observed in schizophrenia. However, divergent findings suggest that often-observed regions exist within a network of susceptible regions. We conducted structural covariance analysis of multiple morphometric features of 358 regions from 79 first-episode anti-psychotic-naive psychosis patients (FEAP) and 68 healthy controls to investigate network differences.Methods Using graph theoretic methods, we investigated structural covariance network of Freesurfer-derived cortical gray matter volumes, thickness, curvature, and surface area using the Brain Connectivity Toolbox within MATLAB, compared network modularity using the Community Detection Toolbox within MATLAB, and examined the resilience of the network using simulated attacks.Results FEAP showed decreased heterogeneity of cortical volumes compared to controls which was driven by decreased heterogeneity of cortical thickness but not surface area. Reduced morphological heterogeneity was associated with less differentiated community structure in FEAP compared to controls. FEAP patients, in general, showed less resilient networks that were more vulnerable to attacks on fewer nodes compared to healthy subjects.Conclusions Our findings of decreased heterogeneity may be associated with FEAP-related pathology since the impact of illness chronicity and treatment are minimized. Contribution of cortical thickness but not surface area covariance network suggests that neurodevelopmental processes affecting the thickness rather than the surface area may be pathophysiologically more significant.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNIMH R0MH1112584 and R01MH115026 (Konasale Prasad, MD); P50 MH045156, Behavioral Neuroscience and Schizophrenia (David Lewis, MD); and NIH/NCRR/GCRC M01 RR00056 (Arthur Levine, MD).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Pittsburgh Institutional Review BoardI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.